Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study
暂无分享,去创建一个
L. Sechi | S. Pilz | M. Novello | C. Catena | G. Colussi | A. Tomaschitz | N. Verheyen | N. Bertin
[1] L. Sechi,et al. Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension. , 2015, American journal of hypertension.
[2] M. Novello,et al. Aldosterone and Left Ventricular Remodeling , 2015, Hormone and Metabolic Research.
[3] L. Sechi,et al. Plasma Aldosterone and Left Ventricular Diastolic Function in Treatment-Naïve Patients With Hypertension: Tissue-Doppler Imaging Study , 2015, Hypertension.
[4] L. Sechi,et al. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies. , 2015, American journal of hypertension.
[5] J. Funder. Primary aldosteronism and salt , 2014, Pflügers Archiv - European Journal of Physiology.
[6] C. Catena,et al. Salt, Hypertension, and Cardiovascular Disease , 2014 .
[7] C. Catena,et al. Aldosterone, organ damage and dietary salt , 2013, Clinical and experimental pharmacology & physiology.
[8] F. Veglio,et al. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. , 2013, The Journal of clinical endocrinology and metabolism.
[9] L. Sechi,et al. Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels. , 2013, American journal of hypertension.
[10] M. Stowasser,et al. Salt, aldosterone and hypertension , 2013, Journal of Human Hypertension.
[11] C. Catena,et al. Aldosterone and the Heart: From Basic Research to Clinical Evidence , 2011, Hormone and Metabolic Research.
[12] R. Wachter,et al. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. , 2012, European heart journal.
[13] R. Carey. Double-barreled assault by aldosterone and salt on the heart. , 2011, The Journal of clinical endocrinology and metabolism.
[14] T. Marwick,et al. Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study. , 2011, The Journal of clinical endocrinology and metabolism.
[15] C. Catena,et al. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. , 2010, American journal of hypertension.
[16] P. Fesler,et al. Dietary Sodium, Aldosterone, and Left Ventricular Mass Changes During Long-Term Inhibition of the Renin-Angiotensin System , 2010, Hypertension.
[17] M. Herregods,et al. Independent Relations of Left Ventricular Structure With the 24-Hour Urinary Excretion of Sodium and Aldosterone , 2009, Hypertension.
[18] X. Jeunemaître,et al. Dietary sodium alters the prevalence of electrocardiogram determined left ventricular hypertrophy in hypertension. , 2009, American journal of hypertension.
[19] M. Bazzocchi,et al. Intrarenal hemodynamics in primary aldosteronism before and after treatment. , 2009, The Journal of clinical endocrinology and metabolism.
[20] F. Beuschlein,et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. , 2009, The Journal of clinical endocrinology and metabolism.
[21] D. Levy,et al. Relations of Biomarkers Representing Distinct Biological Pathways to Left Ventricular Geometry , 2008, Circulation.
[22] D. Rizzoni,et al. Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism , 2008, Hypertension.
[23] C. Yabe-Nishimura,et al. Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1 , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[24] P. Strazzullo,et al. Primary aldosteronism: cardiovascular, renal and metabolic implications , 2008, Trends in Endocrinology & Metabolism.
[25] H. Matsubara,et al. Aldosterone Nongenomically Produces NADPH Oxidase–Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis , 2008, Hypertension Research.
[26] L. Sechi,et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. , 2008, Archives of internal medicine.
[27] S. Mccune,et al. Salt-Induced Cardiac Hypertrophy Is Independent of Blood Pressure and Endothelin in Obese, Heart Failure-Prone SHHF Rats , 2008, Clinical and experimental hypertension.
[28] J. Funder. Mineralocorticoid receptor activation and oxidative stress. , 2007, Hypertension.
[29] L. Sechi,et al. Long-Term Cardiac Effects of Adrenalectomy or Mineralocorticoid Antagonists in Patients With Primary Aldosteronism , 2007, Hypertension.
[30] A. Dominiczak,et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.
[31] R. Schmieder,et al. High sodium intake modulates left ventricular mass in patients with G expression of +1675 G/A angiotensin II receptor type 2 gene , 2007, Journal of hypertension.
[32] A. Dominiczak,et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.
[33] A. Yamashina,et al. Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[34] J. Sowers,et al. Hypertension and Cardiovascular Disease , 2006 .
[35] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[36] J. Sharman,et al. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. , 2005, The Journal of clinical endocrinology and metabolism.
[37] J. Funder. Is aldosterone bad for the heart? , 2004, Trends in Endocrinology & Metabolism.
[38] W. Young,et al. Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents , 2004 .
[39] N. Reichek,et al. Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential , 2003 .
[40] Ricardo Rocha,et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[41] C. Otto,et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[42] G. Adler,et al. Cardiac Damage Prevention by Eplerenone: Comparison With Low Sodium Diet or Potassium Loading , 2002, Hypertension.
[43] M. Tordoff,et al. Different effects of three aldosterone treatments on plasma aldosterone and salt intake , 1993, Physiology & Behavior.
[44] J. Laragh,et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. , 1992, Journal of the American College of Cardiology.
[45] T. Ogihara,et al. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension. , 1987, Journal of clinical hypertension.
[46] R. Sloan,et al. Estimating Dietary Sodium Intake in Individuals Receiving a Randomly Fluctuating Intake , 1982, Hypertension.
[47] R. Gaunt,et al. Aldosterone and hypertension. , 1957, Archives internationales de pharmacodynamie et de therapie.